Form 8-K - Current report:
SEC Accession No. 0001104659-24-006287
Filing Date
2024-01-24
Accepted
2024-01-24 16:55:48
Documents
12
Period of Report
2024-01-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm243972d1_8k.htm   iXBRL 8-K 70454
  Complete submission text file 0001104659-24-006287.txt   254026

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imgn-20240124.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE imgn-20240124_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imgn-20240124_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT tm243972d1_8k_htm.xml XML 3186
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

EIN.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 24557190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)